Citation Impact
Citing Papers
Patterns of Cancer Incidence, Mortality, and Prevalence Across Five Continents: Defining Priorities to Reduce Cancer Disparities in Different Geographic Regions of the World
2006 Standout
Perioperative Chemotherapy Compared With Surgery Alone for Resectable Gastroesophageal Adenocarcinoma: An FNCLCC and FFCD Multicenter Phase III Trial
2011 Standout
Results of a Pivotal Phase II Study of Brentuximab Vedotin for Patients With Relapsed or Refractory Hodgkin's Lymphoma
2012 Standout
Antitumor Action of the MET Tyrosine Kinase Inhibitor Crizotinib (PF-02341066) in Gastric Cancer Positive for MET Amplification
2012
PARP inhibitors: Synthetic lethality in the clinic
2017 StandoutScience
Diabetic foot disorders: A clinical practice guideline
2000
Challenges in the Treatment of Chronic Wounds
2015 Standout
Neutrophil/lymphocyte ratio predicts chemotherapy outcomes in patients with advanced colorectal cancer
2011
Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial
2010 Standout
MET is required for the recruitment of anti-tumoural neutrophils
2015 Nature
Metastatic tumor evolution and organoid modeling implicate TGFBR2as a cancer driver in diffuse gastric cancer
2014
Engineering precision nanoparticles for drug delivery
2020 Standout
The global burden of diabetic foot disease
2005 Standout
CD44: a validated target for improved delivery of cancer therapeutics
2012
K-ras Mutations and Benefit from Cetuximab in Advanced Colorectal Cancer
2008 Standout
Oncology Meets Immunology: The Cancer-Immunity Cycle
2013 Standout
Maternal Immune Activation Alters Fetal Brain Development through Interleukin-6
2007 Standout
A systematic review of foot ulcer in patients with Type 2 diabetes mellitus. II: treatment
1999
Wound healing and its impairment in the diabetic foot
2005 Standout
PARP inhibitor combination therapy
2016
Management of Diabetic Foot Ulcers
2012
First-Line Crizotinib versus Chemotherapy in ALK-Positive Lung Cancer
2014 Standout
The neuropoietic cytokine family in development, plasticity, disease and injury
2007
Smart cancer nanomedicine
2019
Understanding the tumor immune microenvironment (TIME) for effective therapy
2018 Standout
The tumour microenvironment after radiotherapy: mechanisms of resistance and recurrence
2015 Standout
Alectinib versus Crizotinib in Untreated ALK-Positive Non–Small-Cell Lung Cancer
2017 Standout
Coordinated regulation of myeloid cells by tumours
2012 Standout
A systematic review of foot ulcer in patients with Type 2 diabetes mellitus. I: prevention
1999
Identification of patients at risk for diabetic foot
2001
Colorectal cancer
2019 Standout
From Krebs to clinic: glutamine metabolism to cancer therapy
2016 Standout
Treating ALK-positive lung cancer—early successes and future challenges
2012
Intraoperative tumor-specific fluorescence imaging in ovarian cancer by folate receptor-α targeting: first in-human results
2011 Standout
HYPOXIA AND ANGIOGENESIS IN PANCREATIC CANCER
2006
Body surface area in normal-weight, overweight, and obese adults. A comparison study
2006
Diabetes and Atherosclerosis
2002 Standout
Genomic Analysis of Reactive Astrogliosis
2012 Standout
Chemotherapy-induced peripheral neuropathy: Prevention and treatment strategies
2008
Diabetic foot ulcers
2003 Standout
Extensive use of peripheral angioplasty, particularly infrapopliteal, in the treatment of ischaemic diabetic foot ulcers: clinical results of a multicentric study of 221 consecutive diabetic subjects
2002
EGFR in colorectal cancer: more than a simple receptor
2006
Matching chelators to radiometals for radiopharmaceuticals
2013 Standout
Trends in cancer survival in 11 European populations from 1990 to 2009: a model-based analysis
2008
Gastric cancer
2020 Standout
Effect of Duloxetine on Pain, Function, and Quality of Life Among Patients With Chemotherapy-Induced Painful Peripheral Neuropathy
2013 Standout
Increased Lactate Secretion by Cancer Cells Sustains Non-cell-autonomous Adaptive Resistance to MET and EGFR Targeted Therapies
2018
Crizotinib in the Treatment of Non–Small-Cell Lung Cancer
2013
Efficacy of gabapentin in the management of chemotherapy‐induced peripheral neuropathy
2007
Ferroptosis: mechanisms, biology and role in disease
2021 Standout
Preventing Foot Ulcers in Patients With Diabetes
2005 Standout
Cancer-related inflammation and treatment effectiveness
2014 Standout
Chemotherapy with Preoperative Radiotherapy in Rectal Cancer
2006 Standout
Lysosome-targeting chimaeras for degradation of extracellular proteins
2020 StandoutNatureNobel
Modeling Development and Disease with Organoids
2016 Standout
Updates on Management of Gastric Cancer
2019
Survival After Gastric Adenocarcinoma Resection: Eighteen-Year Experience at a Single Institution
2005
Efficacy of lamotrigine in the management of chemotherapy‐induced peripheral neuropathy
2008
Methods for Noninvasive Imaging of Tissue Hypoxia
2007
Vandetanib (ZD6474), a Dual Inhibitor of Vascular Endothelial Growth Factor Receptor (VEGFR) and Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinases: Current Status and Future Directions
2009
Guidelines for the Early Management of Patients With Acute Ischemic Stroke
2013 Standout
Charcot neuroarthropathy in diabetes mellitus
2002
Photothermal therapy and photoacoustic imaging via nanotheranostics in fighting cancer
2018 Standout
Data maturity and follow-up in time-to-event analyses
2018
Fluorine in Pharmaceutical Industry: Fluorine-Containing Drugs Introduced to the Market in the Last Decade (2001–2011)
2013 Standout
MET amplification in metastatic colorectal cancer: an acquired response to EGFR inhibition, not a de novo phenomenon
2016
Tumour stem cells and drug resistance
2005 Standout
Transferrin receptor 1 in cancer: a new sight for cancer therapy.
2018
ACC/AHA 2005 Practice Guidelines for the Management of Patients With Peripheral Arterial Disease (Lower Extremity, Renal, Mesenteric, and Abdominal Aortic)
2006 Standout
ALK inhibitors in non-small cell lung cancer: crizotinib and beyond.
2014
89Zr-Radiolabeled Trastuzumab Imaging in Orthotopic and Metastatic Breast Tumors
2012
Selective Killing of Hypoxia-Inducible Factor-1–Active Cells Improves Survival in a Mouse Model of Invasive and Metastatic Pancreatic Cancer
2009 StandoutNobel
Peripheral Neuropathy Induced by Microtubule-Stabilizing Agents
2006
Degradable Controlled-Release Polymers and Polymeric Nanoparticles: Mechanisms of Controlling Drug Release
2016 Standout
Fluorescence Lifetime Measurements and Biological Imaging
2010 Standout
NCCN Task Force Report: Management of Neuropathy in Cancer
2009
Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: American Society of Clinical Oncology Clinical Practice Guideline
2014 Standout
Neoadjuvant Capecitabine and Oxaliplatin Followed by Synchronous Chemoradiation and Total Mesorectal Excision in Magnetic Resonance Imaging–Defined Poor-Risk Rectal Cancer
2006
Targeted delivery of methotrexate to epidermal growth factor receptor–positive brain tumors by means of cetuximab (IMC-C225) dendrimer bioconjugates
2006
New Ulceration, New Major Amputation, and Survival Rates in Diabetic Subjects Hospitalized for Foot Ulceration From 1990 to 1993
2001
Hyperbaric oxygen therapy for chronic wounds
2015
Wound Healing: A Cellular Perspective
2018 Standout
Compact Plasmonic Blackbody for Cancer Theranosis in the Near-Infrared II Window
2018
Metabolic reprogramming and cancer progression
2020 StandoutScience
Targeting Receptor Tyrosine Kinase MET in Cancer: Small Molecule Inhibitors and Clinical Progress
2013
Nanotechnology Strategies To Advance Outcomes in Clinical Cancer Care
2017
Reactive Oxygen Species (ROS)-Based Nanomedicine
2019 Standout
Targeting Tumor Microenvironment for Cancer Therapy
2019
Minimally Invasive versus Abdominal Radical Hysterectomy for Cervical Cancer
2018 Standout
Management of Gastroesophageal Tumors
2007
A series of systematic reviews to inform a decision analysis for sampling and treating infected diabetic foot ulcers
2006
Progress and Promise of FDG-PET Imaging for Cancer Patient Management and Oncologic Drug Development
2005
Overcoming the Blood–Brain Barrier: The Role of Nanomaterials in Treating Neurological Diseases
2018
Cellular and molecular basis of wound healing in diabetes
2007 Standout
Exogenous/Endogenous‐Triggered Mesoporous Silica Cancer Nanomedicine
2018
Dendrimers Designed for Functions: From Physical, Photophysical, and Supramolecular Properties to Applications in Sensing, Catalysis, Molecular Electronics, Photonics, and Nanomedicine
2010 Standout
Presence of Intratumoral Neutrophils Is an Independent Prognostic Factor in Localized Renal Cell Carcinoma
2009
Photothermal Nanomaterials: A Powerful Light-to-Heat Converter
2023 Standout
Cost-Effectiveness of Prevention and Treatment of the Diabetic Foot
2004
A Phase I Trial of a Potent P-Glycoprotein Inhibitor, Zosuquidar Trihydrochloride (LY335979), Administered Intravenously in Combination with Doxorubicin in Patients with Advanced Malignancy
2004
Amitriptyline in the prevention of chemotherapy-induced neuropathic symptoms.
2009
Rational Design of Cancer Nanomedicine for Simultaneous Stealth Surface and Enhanced Cellular Uptake
2019
Carbon dots as a new class of nanomedicines: Opportunities and challenges
2021
Dose translation from animal to human studies revisited
2007 Standout
Works of Michael Michael being referenced
Oxaliplatin combined with infusional 5-fluorouracil and concomitant radiotherapy in inoperable and metastatic rectal cancer: a phase I trial
2005
Adjuvant and neoadjuvant therapy for gastric cancer using epirubicin/cisplatin/5-fluorouracil (ECF) and alternative regimens before and after chemoradiation
2003
Rational use of trastuzumab in metastatic and locally advanced breast cancer: Implications of recent research
2010
Open-label phase I trial of vandetanib in combination with mFOLFOX6 in patients with advanced colorectal cancer
2008
Prognostic Factors Predictive of Response and Survival to a Modified FOLFOX Regimen: Importance of an Increased Neutrophil Count
2006
TOPGEAR: a randomised phase III trial of perioperative ECF chemotherapy versus preoperative chemoradiation plus perioperative ECF chemotherapy for resectable gastric cancer (an international, intergroup trial of the AGITG/TROG/EORTC/NCIC CTG)
2015
Implications of dose rounding of chemotherapy to the nearest vial size
2003
Addition of Gabapentin to a Modified FOLFOX Regimen Does Not Reduce Oxaliplatin-Induced Neurotoxicity
2006
Change in Major Amputation Rate in a Center Dedicated to Diabetic Foot Care During the 1980s: Prognostic Determinants for Major Amputation
1998
Molecular biology of anal squamous cell carcinoma: implications for future research and clinical intervention
2015
FDG-PET-Detected Extracranial Metastasis in Patients with Non-Small Cell Lung Cancer Undergoing Staging for Surgery or Radical Radiotherapy
2003
A Pilot Human Evaluation of a Formulation of Irinotecan and Hyaluronic Acid in 5-Fluorouracil-Refractory Metastatic Colorectal Cancer Patients
2008
Beyond 5-fluorouracil: new horizons in systemic therapy for advanced colorectal cancer
2005
TOPGEAR: A Randomized, Phase III Trial of Perioperative ECF Chemotherapy with or Without Preoperative Chemoradiation for Resectable Gastric Cancer: Interim Results from an International, Intergroup Trial of the AGITG, TROG, EORTC and CCTG
2017
Phase I Dose-Finding and Pharmacokinetic Study of Paclitaxel and Carboplatin With Oral Valspodar in Patients With Advanced Solid Tumors
2000
Safety and tolerability of veliparib combined with capecitabine plus radiotherapy in patients with locally advanced rectal cancer (LARC): Final results of a phase Ib study.
2015
Adjunctive Systemic Hyperbaric Oxygen Therapy in Treatment of Severe Prevalently Ischemic Diabetic Foot Ulcer: A randomized study
1996
A Randomized, Double-Blinded, Placebo-Controlled Phase II Trial of Recombinant Human Leukemia Inhibitory Factor (rhuLIF, Emfilermin, AM424) to Prevent Chemotherapy-Induced Peripheral Neuropathy
2005
Adjuvant Therapy in Gastric Cancer
2005
MET Amplification Identifies a Small and Aggressive Subgroup of Esophagogastric Adenocarcinoma With Evidence of Responsiveness to Crizotinib
2011
Bridging Bio–Nano Science and Cancer Nanomedicine
2017